What to Look for in Procter & Gamble Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What to Look for in Procter & Gamble Earnings

© courtesy of Procter & Gamble Co.

Procter & Gamble Co. (NYSE: PG) is scheduled to release its fiscal fourth-quarter earnings report before the markets open on Tuesday. The consensus estimates call for $0.74 in earnings per share (EPS) on revenue of $15.83 billion. In the same period of last year, the company posted EPS of $0.93 and $17.79 billion in revenue.

This stock is trading up from this time last year, in part because it has a very large 65% of sales directed to foreign customers, which should improve as the dollar’s run has slowed dramatically. It is a solid consumer staples stock for conservative investors to consider.

The company sells lots of very well-known household items that are essential for everyday life, and it operates through five segments: Beauty, Hair and Personal Care; Grooming; Health Care; Fabric Care and Home Care; and Baby, Feminine and Family Care.

The company posted an earnings beat for the fiscal third quarter, and analysts feel that the new focus on a slimmed down product portfolio will help spur earnings growth and return the company to its long-time premium consumer staples multiple.

[nativounit]

A few analysts weighed in on P&G prior to the release of the earnings report:

  • Deutsche Bank reiterated a Buy rating with a $92 price target.
  • Stifel has a Buy rating with a $92 price target.
  • Goldman Sachs reiterated a Neutral rating with an $88 price target.
  • Jefferies reiterated a Buy rating with a $95 price target.
  • Atlantic Securities initiated coverage with a Neutral rating and an $84 price target.
  • SunTrust reiterated a Buy rating.
  • B. Riley reiterated a Neutral rating with a $74 price target.

So far in 2016, P&G has outperformed the broad markets, with the stock up about 11%. Over the past 52 weeks, the stock is up about 15%.

Its shares were trading up 1% at $86.49 on Monday, with a consensus analyst price target of $86.47 and a 52-week trading range of $65.02 to $86.89.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618